When 71-year-old Marjatta started losing her balance and forgetting familiar faces, her family feared the worst: a diagnosis of dementia that would slowly erase who she was. But what they didn't know was that her symptoms pointed to a condition that doctors can actually fix. Now, a breakthrough from researchers in Finland could help thousands of families receive that same life-changing answer sooner.
Scientists at the University of Eastern Finland have identified a new way to predict which patients with idiopathic normal pressure hydrocephalus, or iNPH, will respond to a relatively simple brain surgery. The condition affects older adults and causes a distinctive trio of symptoms: gait problems, urinary urgency, and cognitive decline. Unlike most forms of dementia, iNPH can often be reversed with timely surgery to implant a shunt that drains excess fluid from the brain. But here's the challenge: doctors haven't had a reliable way to know beforehand which patients will benefit.
The research team, working with brain scans from 170 iNPH patients, used advanced 3D imaging and machine learning to analyze the geometry of the brain's lateral ventricles. They discovered that a marker called asphericity, which measures how irregular or elongated the ventricles appear, was strongly linked to better surgical outcomes. Patients whose ventricles showed higher asphericity were significantly more likely to improve after shunt surgery.
Lead researcher Andrius Penkauskas explained the stakes clearly. "Our findings suggest that quantifying the 3D geometry of the brain ventricles can provide important clues about which patients are likely to benefit from surgery," he said. "This advancement brings us a step closer to better identifying iNPH patients who will truly benefit from complex brain surgery and sparing many from the suffering of ineffective treatment."
The implications are significant. Currently, up to 30 percent of patients who undergo shunt surgery for iNPH don't experience meaningful improvement. By using asphericity as a screening tool, neurologists and neurosurgeons could better target surgery to those most likely to benefit, while avoiding invasive procedures for those who won't respond.
The study, published in the journal Fluids and Barriers of the CNS, represents a step toward more personalized care for a condition that remains widely underdiagnosed. Researchers hope that wider adoption of geometric markers like asphericity could eventually lead to earlier detection and treatment, giving more patients like Marjatta a chance at recovery.